Pharma Foods International Co., Ltd. (TYO:2929)
917.00
+10.00 (1.10%)
May 2, 2025, 3:30 PM JST
TYO:2929 Income Statement
Financials in millions JPY. Fiscal year is August - July.
Millions JPY. Fiscal year is Aug - Jul.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Jan '25 Jan 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 | Jul '20 Jul 31, 2020 | 2015 - 2019 |
Revenue | 60,352 | 62,147 | 68,572 | 60,185 | 46,752 | 15,353 | Upgrade
|
Revenue Growth (YoY) | -7.27% | -9.37% | 13.94% | 28.73% | 204.51% | 45.77% | Upgrade
|
Cost of Revenue | 12,416 | 13,395 | 13,293 | 12,077 | 7,027 | 3,178 | Upgrade
|
Gross Profit | 47,936 | 48,752 | 55,279 | 48,108 | 39,725 | 12,175 | Upgrade
|
Selling, General & Admin | 42,531 | 42,561 | 50,757 | 46,211 | 33,486 | 10,961 | Upgrade
|
Research & Development | 1,134 | 978 | 840 | 766 | 522 | 437 | Upgrade
|
Operating Expenses | 43,734 | 43,638 | 51,669 | 47,028 | 34,051 | 11,374 | Upgrade
|
Operating Income | 4,202 | 5,114 | 3,610 | 1,080 | 5,674 | 801 | Upgrade
|
Interest Expense | -76 | -62 | -48 | -26 | -12 | -8 | Upgrade
|
Interest & Investment Income | 34 | 29 | 27 | 38 | 6 | 5 | Upgrade
|
Earnings From Equity Investments | -102 | -35 | -82 | 5 | 16 | 1 | Upgrade
|
Currency Exchange Gain (Loss) | -5 | 4 | 8 | 37 | 16 | -7 | Upgrade
|
Other Non Operating Income (Expenses) | 297 | 198 | 76 | 130 | 66 | 56 | Upgrade
|
EBT Excluding Unusual Items | 4,350 | 5,248 | 3,591 | 1,264 | 5,766 | 848 | Upgrade
|
Gain (Loss) on Sale of Investments | -113 | -113 | -50 | 81 | - | - | Upgrade
|
Gain (Loss) on Sale of Assets | - | - | -6 | 77 | - | - | Upgrade
|
Asset Writedown | -101 | -101 | - | - | -1 | -1 | Upgrade
|
Other Unusual Items | -1 | -1 | 8 | 1 | - | - | Upgrade
|
Pretax Income | 4,135 | 5,033 | 3,543 | 1,423 | 5,765 | 847 | Upgrade
|
Income Tax Expense | 1,469 | 1,828 | 462 | 1,797 | 1,924 | 157 | Upgrade
|
Earnings From Continuing Operations | 2,666 | 3,205 | 3,081 | -374 | 3,841 | 690 | Upgrade
|
Net Income | 2,666 | 3,205 | 3,081 | -374 | 3,841 | 690 | Upgrade
|
Net Income to Common | 2,666 | 3,205 | 3,081 | -374 | 3,841 | 690 | Upgrade
|
Net Income Growth | -44.03% | 4.03% | - | - | 456.67% | 38.28% | Upgrade
|
Shares Outstanding (Basic) | 28 | 28 | 29 | 29 | 29 | 29 | Upgrade
|
Shares Outstanding (Diluted) | 28 | 28 | 29 | 29 | 29 | 29 | Upgrade
|
Shares Change (YoY) | -1.84% | -1.51% | -0.47% | -0.18% | 0.04% | 0.04% | Upgrade
|
EPS (Basic) | 94.22 | 112.69 | 106.70 | -12.89 | 132.20 | 23.76 | Upgrade
|
EPS (Diluted) | 94.22 | 112.69 | 106.70 | -12.89 | 132.14 | 23.76 | Upgrade
|
EPS Growth | -42.98% | 5.62% | - | - | 456.13% | 38.26% | Upgrade
|
Free Cash Flow | 1,780 | 4,645 | 5,739 | -6,532 | 5,784 | -1,447 | Upgrade
|
Free Cash Flow Per Share | 62.91 | 163.32 | 198.74 | -225.13 | 198.99 | -49.80 | Upgrade
|
Dividend Per Share | 27.500 | 25.000 | 22.000 | 20.000 | 20.000 | 8.500 | Upgrade
|
Dividend Growth | 25.00% | 13.64% | 10.00% | - | 135.29% | - | Upgrade
|
Gross Margin | 79.43% | 78.45% | 80.62% | 79.93% | 84.97% | 79.30% | Upgrade
|
Operating Margin | 6.96% | 8.23% | 5.27% | 1.79% | 12.14% | 5.22% | Upgrade
|
Profit Margin | 4.42% | 5.16% | 4.49% | -0.62% | 8.22% | 4.49% | Upgrade
|
Free Cash Flow Margin | 2.95% | 7.47% | 8.37% | -10.85% | 12.37% | -9.43% | Upgrade
|
EBITDA | 5,161 | 6,021 | 4,156 | 1,600 | 5,855 | 952 | Upgrade
|
EBITDA Margin | 8.55% | 9.69% | 6.06% | 2.66% | 12.52% | 6.20% | Upgrade
|
D&A For EBITDA | 959 | 907 | 546 | 520 | 181 | 151 | Upgrade
|
EBIT | 4,202 | 5,114 | 3,610 | 1,080 | 5,674 | 801 | Upgrade
|
EBIT Margin | 6.96% | 8.23% | 5.27% | 1.79% | 12.14% | 5.22% | Upgrade
|
Effective Tax Rate | 35.53% | 36.32% | 13.04% | 126.28% | 33.37% | 18.54% | Upgrade
|
Advertising Expenses | - | 30,787 | 38,865 | 35,748 | 24,860 | 7,376 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.